Friday November 27 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Neuroendocrine Tumors

Download PDF containing detailed information.PDF Version

Image Results

Loading...

Recent Publications on Neuroendocrine Tumors:

Pubmed Logo
Compound heterozygous mutation with a novel splice donor region DNA sequence variant in the succinate dehydrogenase subunit B gene in malignant paraganglioma.
Pheochromocytoma and paraganglioma (PGL) are rare neuroendocrine tumors in...
21st November, 2009
Department of Pediatrics, University of Mississippi Medical Center, Pediatr Blood Cancer. 2009 Nov 19.
DOI Direct Link
Expression of Reg IV and Hath1 in neuroendocrine neoplasms.
Reg IV (RELP), a Regenerating protein family member, is constitutively...
20th November, 2009
Department of Pathology, Haartman Institute, University of Helsinki, Histol Histopathol. 2010 Jan;25(1):63-72.
ZM447439, a Novel Promising Aurora Kinase Inhibitor, Provokes Antiproliferative and Proapoptotic Effects Alone and in Combination with Bio- and Chemotherapeutic Agents in Gastroenteropancreatic Neuroendocrine Tumor Cell Lines.
Background: Therapeutic approaches to gastroenteropancreatic...
20th November, 2009
Gastroenterologie/Infektiologie/Rheumatologie, Medizinische Klinik I, Neuroendocrinology. 2009 Nov 14.
DOI Direct Link
Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway.
PURPOSE: We investigated the global gene expression in a large panel of...
18th November, 2009
Departments of Pathology and Surgical and Gastroenterological Sciences, J Clin Oncol. 2009 Nov 16.
DOI Direct Link
Carcinoid tumors and small-cell carcinomas of the gallbladder and extrahepatic bile ducts: a comparative study based on 221 cases from the Surveillance, Epidemiology, and End Results Program.
Primary neuroendocrine tumors of the gallbladder (GB) and extrahepatic...
18th November, 2009
Instituto Nacional de Ciencias Medicas y Nutricion, CP 14000 Mexico City, Ann Diagn Pathol. 2009 Dec;13(6):378-83.
DOI Direct Link

View more research publications.

Press Releases About Neuroendocrine Tumors:

BioPortfolio Logo
AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 24th November, 2009 AETERNA ZENTARIS INC.
Primary efficacy endpoint has been met for patients with advanced-stage or recurrent endometrial cancer QUEBEC CITY, Nov. 24 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS;
Scientific Presentations at 2009 ASTRO Meeting Highlight RapidArc(R) Radiotherapy Technology from Varian Medical Systems 10th November, 2009 Varian Medical Systems, Inc.
CHICAGO, Nov. 10 /PRNewswire-FirstCall/ -- Clinicians using RapidArc® radiotherapy technology for fast, precise, non-invasive cancer treatments have found that they are able to substantially reduce
AEterna Zentaris Announces Positive Preliminary Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Ovarian Cancer 2nd November, 2009 AETERNA ZENTARIS INC.
Preliminary evaluation after completion of treatment phase shows that primary efficacy endpoint has been met for patients with advanced-stage platinum-resistant, taxane-pretreated ovarian
Reportlinker Adds Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment 26th October, 2009 Reportlinker
-- A focus on "engineered" antibodies Monoclonal Antibodies: Pipeline Analysis and Competitive Assessment reviews the broad drug development effort that is focused on bringing
Ascenta Therapeutics Announces Presentation of Results From a Dose-Ranging Study of AT-101 With Standard Therapy in Patients With Glioblastoma Multiforme 26th October, 2009 Ascenta Therapeutics, Inc.
MALVERN, Pa., Oct. 26 /PRNewswire/ -- Ascenta Therapeutics announced today that encouraging results from a Phase I dose-escalation study of two combination therapy regimens containing AT-101, an oral,

BioNews Results for Neuroendocrine Tumors:

RSS Logo
BioPortfolio Logo
Biochemical Testing for Neuroendocrine Tumors
MDLinx:  Oct 23 2009 11:13AM Matching: neuroendocrine tumors
Molecular Insight Pharmaceuticals Presents Azedra Efficacy Data in Neuroendocrine Tumors
Pharma Live:  Oct 6 2009 2:39AM Matching: neuroendocrine tumors

Neuroendocrine Tumors Patents:

USPTO Logo
US Patent No.Title
7449554 Antibodies against the PRO4977 polypeptides
7488586 PRO4409 polypeptides
7488588 Compounds related to or derived from GFR .alpha.4 and their use
7488796 PRO1269 polypeptides
7491797 PRO6308 polypeptide

View more patents.

Companies working in the area of Neuroendocrine Tumors from Bioportfolio's Biocorporate database :

BioPortfolio Logo
Company Name

Tercica

Tercica, Inc., based in Brisbane, Calif., is a biopharmaceutical company committed to improving endocrine health. We are helping patients by partnering with the scientific and medical community to...
www.tercica.com/        View full profile
Thumbshot

Molecular Insight Pharmaceuticals

Molecular Insight Pharmaceuticals, Inc. is focused on the research, development and commercialization of innovative molecular imaging pharmaceuticals and targeted radiotherapeutics to diagnose, treat...
www.molecularinsight.com/        View full profile
Thumbshot

BioPortfolio Ltd. offers e-mail and postal lists for Neuroendocrine Tumors scientists - we have details of around 291 individuals working on Neuroendocrine Tumors .


This page has been viewed 461 times
Recent Search Terms used to find this page: neuroendocrine glioma tumors | neuroendocrine tumour, e-medicine | neuroendocrine tumors | neuroendocrine tumors news | neuroendocrine tumors of pancreas | neuroendrocrine 2009 | Predicting neuroendocrine tumor (carcinoid) neoplasia using gene expression profiling and supervised machine learning | video of pancreas neuroendocrine tumor | any new news on neuro endocrine tumors | .
Browse BioPortfolio's InDepth service - alphabetically: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z or by Most Publications, recently searched for, or most viewed.

Search for Neuroendocrine Tumors across BioPortfolio, or for Neuroendocrine Tumors Research Reports
Wikipedia excerpt, where present, licenced under the GNU Free Documentation License. Resources from the NCBI applied. Selected MeSH subject headings created and maintained by the US NLM are used in conjunction with additional keywords. 2006-2008 MeSH. Thumbshots from Thumbshots.org

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.